pocketful logo light
pocketful logo light
Bal Pharma Ltd logo

Bal Pharma Ltd

NSE: BALPHARMA BSE: 524824

₹108.16

(1.11%)

Tue, 29 Sept 2026, 03:19 pm

Bal Pharma Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters50.8650.8650.8650.8650.86
FII0.140.140.220.150.14
DII00000
Public49.0149.0148.9248.9949.00
Government00000

Bal Pharma Ltd Shareholding Pattern

The Bal Pharma Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Bal Pharma Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.

Bal Pharma Ltd (NSE: BALPHARMA, BSE: 524824) operates in the Health technology sector and Pharmaceuticals: major industry. Monitoring the Bal Pharma Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.

Bal Pharma Ltd Shareholding Pattern (Latest)

The latest Bal Pharma Ltd shareholding for Mar 2026 is:

  • Promoters: 50.86%
  • FII: 0.14%
  • DII: 0%
  • Public: 49.01%
  • Government: 0%

Promoter holding in Bal Pharma Ltd remains stable, reflecting consistent long-term commitment.

Bal Pharma Ltd Promoter Holding Trend

Promoter shareholding plays a crucial role in evaluating management confidence in Bal Pharma Ltd.

  • Mar 2026: 50.86%
  • Dec 2025: 50.86%
  • Sept 2025: 50.86%
  • Jun 2025: 50.86%
  • Mar 2025: 50.86%

Promoter stake remains largely stable, showing consistent ownership structure.

Bal Pharma Ltd FII Shareholding Trend

Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Bal Pharma Ltd.

  • Mar 2026: 0.14%
  • Dec 2025: 0.14%
  • Sept 2025: 0.22%
  • Jun 2025: 0.15%
  • Mar 2025: 0.14%

FII holding has declined, suggesting cautious sentiment among foreign investors.

Bal Pharma Ltd DII Shareholding Trend

Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.

  • Mar 2026: 0%
  • Dec 2025: 0%
  • Sept 2025: 0%
  • Jun 2025: 0%
  • Mar 2025: 0%

DII holdings remain stable, reflecting steady institutional participation.

Bal Pharma Ltd Public Shareholding Trend

Public shareholding represents retail and non-institutional investors.

  • Mar 2026: 49.01%
  • Dec 2025: 49.01%
  • Sept 2025: 48.92%
  • Jun 2025: 48.99%
  • Mar 2025: 49.00%

Public holding remains stable with consistent retail participation.

Bal Pharma Ltd Government Holding

Government holding in Bal Pharma Ltd currently stands at 0%.

Bal Pharma Ltd operates without significant government ownership.

Bal Pharma Ltd Shareholding Analysis Summary

The Bal Pharma Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.

Investors should monitor changes in Bal Pharma Ltd shareholding for signals on institutional sentiment and ownership trends.

Regular monitoring of the Bal Pharma Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.